Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001140361-10-040263
Filing Date
2010-10-06
Accepted
2010-10-06 15:25:36
Documents
2
Period of Report
2010-09-09

Document Format Files

Seq Description Document Type Size
1 FORM 3 doc1.html 3  
1 FORM 3 doc1.xml 3 1698
2 POWER OF ATTORNEY poa1.htm EX-24 11878
  Complete submission text file 0001140361-10-040263.txt   15460
Mailing Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850
Business Address 15245 SHADY GROVE ROAD, SUITE 455 ROCKVILLE MD 20850 2402685300
REXAHN PHARMACEUTICALS, INC. (Issuer) CIK: 0001228627 (see all company filings)

EIN.: 113516358 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address NOVEN PHARMACEUTICALS, INC. 11960 SW 144TH STREET MIAMI FL 33186
Business Address
Brandt Peter C. (Reporting) CIK: 0001434099 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34079 | Film No.: 101111669